Literature DB >> 19898480

Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.

Hiba Mahdi1, Benjamin A Fisher, Henrik Källberg, Darren Plant, Vivianne Malmström, Johan Rönnelid, Peter Charles, Bo Ding, Lars Alfredsson, Leonid Padyukov, Deborah P M Symmons, Patrick J Venables, Lars Klareskog, Karin Lundberg.   

Abstract

Gene-environment associations are important in rheumatoid arthritis (RA) susceptibility, with an association existing between smoking, HLA- DRB1 'shared epitope' alleles, PTPN22 and antibodies to cyclic citrullinated peptides (CCP). Here, we test the hypothesis that a subset of the anti-CCP response, with specific autoimmunity to citrullinated alpha-enolase, accounts for an important portion of these associations. In 1,497 individuals from three RA cohorts, antibodies to the immunodominant citrullinated alpha-enolase CEP-1 epitope were detected in 43-63% of the anti-CCP-positive individuals, and this subset was preferentially linked to HLA-DRB1*04. In a case-control analysis of 1,000 affected individuals and 872 controls, the combined effect of shared epitope, PTPN22 and smoking showed the strongest association with the anti-CEP-1-positive subset (odds ratio (OR) of 37, compared to an OR of 2 for the corresponding anti-CEP-1-negative, anti-CCP-positive subset). We conclude that citrullinated alpha-enolase is a specific citrullinated autoantigen that links smoking to genetic risk factors in the development of RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898480     DOI: 10.1038/ng.480

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  34 in total

1.  Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.

Authors:  Jinhong Peng; Wei Dong; Lu Chen; Tingting Zou; Yipeng Qi; Yingle Liu
Journal:  Mol Cell Biochem       Date:  2006-11-17       Impact factor: 3.396

2.  Estimability and estimation in case-referent studies.

Authors:  O Miettinen
Journal:  Am J Epidemiol       Date:  1976-02       Impact factor: 4.897

Review 3.  Immunity to citrullinated proteins in rheumatoid arthritis.

Authors:  Lars Klareskog; Johan Rönnelid; Karin Lundberg; Leonid Padyukov; Lars Alfredsson
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

5.  The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.

Authors:  Annette H M van der Helm-van Mil; Kirsten N Verpoort; Ferdinand C Breedveld; Tom W J Huizinga; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2006-04

6.  Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.

Authors:  Robert M Plenge; Leonid Padyukov; Elaine F Remmers; Shaun Purcell; Annette T Lee; Elizabeth W Karlson; Frederick Wolfe; Daniel L Kastner; Lars Alfredsson; David Altshuler; Peter K Gregersen; Lars Klareskog; John D Rioux
Journal:  Am J Hum Genet       Date:  2005-11-01       Impact factor: 11.025

7.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

8.  Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.

Authors:  O Snir; M Widhe; C von Spee; J Lindberg; L Padyukov; K Lundberg; A Engström; P J Venables; J Lundeberg; R Holmdahl; L Klareskog; V Malmström
Journal:  Ann Rheum Dis       Date:  2008-07-17       Impact factor: 19.103

9.  Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.

Authors:  Bo Ding; Leonid Padyukov; Emeli Lundström; Mark Seielstad; Robert M Plenge; Jorge R Oksenberg; Peter K Gregersen; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2009-01

10.  Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins.

Authors:  A J Silman; J Newman; A J MacGregor
Journal:  Arthritis Rheum       Date:  1996-05
View more
  126 in total

1.  A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.

Authors:  Wenfeng Tan; Hui Wu; Jian Zhao; Lezlie A Derber; David M Lee; Nancy A Shadick; Doyt L Conn; Edwin A Smith; Vivian H Gersuk; Gerald T Nepom; Larry W Moreland; Daniel E Furst; Susan D Thompson; Beth L Jonas; V Michael Holers; David N Glass; Pojen P Chen; S Louis Bridges; Michael E Weinblatt; Harold E Paulus; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2010-10

2.  GEIRA: gene-environment and gene-gene interaction research application.

Authors:  Bo Ding; Henrik Källberg; Lars Klareskog; Leonid Padyukov; Lars Alfredsson
Journal:  Eur J Epidemiol       Date:  2011-04-26       Impact factor: 8.082

Review 3.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

4.  Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis.

Authors:  Diane van der Woude; Wendimagegn Ghidey Alemayehu; Willem Verduijn; René R P de Vries; Jeanine J Houwing-Duistermaat; Tom W J Huizinga; René E M Toes
Journal:  Nat Genet       Date:  2010-10       Impact factor: 38.330

5.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

6.  Wnt signaling genes of murine chromosome 15 are involved in sex-affected pathways of inflammatory arthritis.

Authors:  Elena Kudryavtseva; Toni S Forde; Andrew D Pucker; Vyacheslav A Adarichev
Journal:  Arthritis Rheum       Date:  2011-10-17

7.  Entropy-based information gain approaches to detect and to characterize gene-gene and gene-environment interactions/correlations of complex diseases.

Authors:  R Fan; M Zhong; S Wang; Y Zhang; A Andrew; M Karagas; H Chen; C I Amos; M Xiong; J H Moore
Journal:  Genet Epidemiol       Date:  2011-11       Impact factor: 2.135

Review 8.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

Review 9.  Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.

Authors:  V Michael Holers
Journal:  Curr Opin Immunol       Date:  2013-11-08       Impact factor: 7.486

10.  Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population.

Authors:  Xian-Bo Zuo; Yu-Jun Sheng; Su-Juan Hu; Jin-Ping Gao; Yang Li; Hua-Yang Tang; Xian-Fa Tang; Hui Cheng; Xian-Yong Yin; Lei-Lei Wen; Liang-Dan Sun; Sen Yang; Yong Cui; Xue-Jun Zhang
Journal:  Rheumatol Int       Date:  2013-10-04       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.